Genetic variability of the fructosamine 3-kinase gene in diabetic patients

Clinical Chemistry and Laboratory Medicine

Volumn 49, Issue 5, 2011, Pages 803-808

  Mosca, Lorena ^a,c,d   Penco, Silvana ^a   Patrosso, Maria C ^a   Marocchi, Alessandro ^a   Lapolla, Annunziata ^b   Sartore, Giovanni ^b   Chilelli, Nino C ^b   Paleari, Renata ^c   Mosca, Andrea ^c  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d Dip Scienze e Tecnologie Biomediche   (Italy)

Author keywords

diabetes; fructosamine 3 kinase (FN3K); glycated hemoglobin; mutation analysis

Indexed keywords

FRUCTOSAMINE; FRUCTOSAMINE 3 KINASE; HEMOGLOBIN A1C; PROTEIN KINASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DIABETIC PATIENT; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GLYCEMIC CONTROL; HAPLOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; ITALY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENETIC VARIATION; GLYCOSYLATION; HAPLOTYPES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR);

EID: 79954553174     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2011.133     Document Type: Article

References (19)

1. Monnier VM. The fructosamine 3-kinase knockout mouse: atool for testing the glycation hypothesis of intracellular protein dam-age in diabetes and aging. Biochem J 2006;399:e11-3.
2. Szwergold BS, Howell S, Beisswenger PJ. Human fructosamine-3-kinase. Purification, sequencing, substrate specificity, and evi-dence for activity in vivo. Diabetes 2001;50:2139-47. (Pubitemid 33643683)
3. Szwergold BS, Beisswenger PJ. Enzymatic deglycation-a new paradigm or an epiphenomenon?. Biochem Soc Trans 2003; 31:1428-32. (Pubitemid 38030993)
4. Conner JR, Beisswenger PJ, Szwergold BS. The expression of the genes for fructosamine-3-kinase and fructosamine-3-kinase-related protein appears to be constitutive and unaffected by envi-ronmental signals. Biochem Biophys Res Commun 2004;323: 932-6. (Pubitemid 39243409)
5. Szwergold BS. Intrinsic toxicity of glucose, due to non-enzy-matic glycation, is controlled in-vivo by deglycations systems including: FN3K-mediated deglycation of fructosamines and transglycation of aldosamines. Med Hypotheses 2005;65:337-48. (Pubitemid 40744765)
6. Collard G, Delpierre G, Stroobant V, Matthijs G, Van Schaftingen E. A mammalian protein homologous to fructosamine-3-kinase acting on psicosamines and ribulosamines but not on fructosa-mines. Diabetes 2003;52:2888-95. (Pubitemid 37466857)
7. Delpierre G, Collard F, Fortpied J, Van Schaftingen E. Fructo-samine 3-kinase is involved in an intracellular glycation pathway in human erythrocytes. Biochem J 2002;365:801-8. (Pubitemid 34864463)
8. Veiga-da-Cunha M, Jacquemin P, Delpierre G, Godfraind C, Théate I, Vertommen D, et al. Increased protein glycation in fructsamine 3-kinase-deficient mice. Biochem J 2006;399:257-64. (Pubitemid 44570288)
9. Delpierre G, Veiga-da-Cunha M, Vertommen D, Buysschaert M, Van Schaftingen E. Variability in erythrocyte fructosamine 3-kinase activity in humans correlates with polymorphisms in the FN3K gene and impacts on haemoglobin glycation at spe-cific sites. Diabetes Metab 2006;32:31-9. (Pubitemid 43872593)
10. 1c levels and the onset of type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 2010;118:209-12.
11. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ. A1c-Derived Average Glucose Study Group, Translating the A1C assay into estimated average glucose values. Diabetes Care 2008;31:1473-8.
12. World Health Organization. Definition, diagnosis and classifi-cation of diabetes mellitus and its complications: Report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. http://wwwstaff.ncl.ac.uk/ philip.home/who- dmc.htm.
13. World Health Organization. Definition and diagnosis of dia-betes mellitus and intermediate hyperglycemia. Report of a WHO/IDF consultation. http://wwwwho.int/diabetes/publica-tions/Definition%20and%20diagnosis%20of%20- diabetes-new pdf.
14. World Medical Association (WMA) declaration of Helsinki. Recommndations guiding physicians in biomedical research involving human subjects. J Am Med Assoc 1997;277:925-26.
15. Browden DW Genetics of diabetes complications. Curr Diab Rep 2002;2:191-200.
16. Pascal SM, Veiga-da-Cunha M, Gilon P, Van Schaftingen E, Jonas JC Effects of fructosamine-3-kinase deficiency on func-tion and survival of mouse pancreatic islets after prolonged culture in high glucose or ribose concentrations. Am J Physiol Endocrinol Metab 2010;298:E586-96.
17. Kosaki K, Udaka T, Okuyama T DHPLC in Clinical molecular diagnostic services. Mol Genet Metab 2005;86:117-23. (Pubitemid 41412167)
18. Frueh FW, Noyer-Weidner M. The use of denaturing high-per-formance liquid chromatography (DHPLC) analysis of genetic variations: impact for diagnostics and pharmacogenetics. Clin Chem Lab Med 2003;41:452-61. (Pubitemid 36592108)
19. Conner JR, Beisswenger PJ, Szwergold BS. Some clues as to the regulation, expression, function, and distribution of fructo-samine-3-kinase and fructosamine-3-kinase-related protein. Ann NY Acad Sci 2005;1043:824-36. (Pubitemid 41123977)